Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Benjamin J. Epstein"'
Autor:
Benjamin J Epstein
Publikováno v:
Vascular Health and Risk Management, Vol 2010, Iss default, Pp 711-722 (2010)
Benjamin J EpsteinDepartments of Pharmacotherapy and Translational Research and Medicine, Colleges of Pharmacy and Medicine, University of Florida, Gainesville, Florida, USA and East Coast Institute for Research, Jacksonville, Florida, USAAbstract: C
Externí odkaz:
https://doaj.org/article/4683f4668de1422e8d2732b1b37f8124
Publikováno v:
Journal of Pharmacy Technology. 29:72-87
Objective: To determine how interactions with cytochrome P450 ( CYP450) isoenzyme pathways may influence the selection of antiplatelet therapy in patients with cardiovascular and cerebrovascular disease. Data Sources: A MEDLINE search (1966-September
Publikováno v:
Clinical Applications of Renin–Angiotensin System Inhibitors. :76-84
Autor:
Benjamin J Epstein
Publikováno v:
Expert Opinion on Pharmacotherapy. 11:2011-2026
Hypertension is the most common preventable cause of cardiovascular morbidity and mortality. Despite the availability of a multitude of antihypertensive drugs, blood pressure (BP) control rates remain poor in the majority of patients with hypertensio
Publikováno v:
Postgraduate Medicine. 122:33-42
Good control of diabetes provides meaningful microvascular risk reduction; yet, patients with type 2 diabetes mellitus commonly languish at unsatisfactory levels of glycated hemoglobin (HbA1c) for protracted periods. A variety of factors contribute t
Autor:
Donna Leverone, Benjamin J Epstein
Publikováno v:
Journal of Pharmacy Practice. 23:101-109
Rheumatoid arthritis (RA) is a chronic, autoimmune disease that affects approximately 1.3 million Americans. It is characterized by inflammation of the joints, most often affecting the hands, hips, and knees. Presently, there is no cure, and the comm
Publikováno v:
Expert Review of Cardiovascular Therapy. 7:1373-1384
The renin-angiotensin system (RAS) is a prime target for cardiovascular drug therapy. Inhibition of the RAS lowers blood pressure and confers protection against cardiovascular and renal events. These latter benefits cannot be entirely attributed to b
Autor:
Shawn D. Anderson, Benjamin J Epstein
Publikováno v:
Expert Review of Cardiovascular Therapy. 7:675-687
The endothelin system is a pivotal player along the continuum of cardiovascular disease. There is convincing evidence that the system not only exerts a potent pressor effect but also promotes end-organ damage independent from blood pressure changes.
Autor:
Molly R Sinert, Benjamin J Epstein
Publikováno v:
Journal of Pharmacy Technology. 25:100-110
Objective: To review studies comparing topiramate with placebo or other migraine prophylaxis agents in order to outline the role of topiramate in the pharmacologic prevention of adult migraine and to provide clinicians with evidence for rationale of
Autor:
Benjamin J Epstein, James R. Taylor
Publikováno v:
Journal of Pharmacy Practice. 22:75-85
Osteoarthritis is common, has considerable health consequences, and will affect increasing numbers of persons in coming years. Nonpharmacological interventions are of paramount importance in achieving adequate symptom control. Acetaminophen and nonst